Skip to content
IQity logo

Vision impairment leads to loss of productivity, increased dependence, and greater demand for social support. Yet, ophthalmology is under immense pressure.

Healthcare systems are overloaded and outdated, built on 50-year old models that are now unsustainable. Without innovation, the system is headed toward collapse.

Designed to deliver superior visual outcomes with greater impact and lower cost.

Diagnosis, treatment, and monitoring of the two leading causes of blindness: Cataract & Glaucoma.

Expected launch – Q3 2027

IQ-Scan

Comprehensive eye exams in minutes – anywhere, anytime.


Expected launch – Q3 2026

IQ-Meter

All-in-one diagnostics and laser treatment for lens surgery.


Expected launch – Q3 2026

IQ-SurgiView

Next Gen surgical visualization with AI assistant.


Expected launch – Q2 2028

IQ-Guard

Viscoelastic with enhanced, multifunctional cell protection.


Expected launch – Q3 2029

IQ-Focus

Continuous depth of focus IOL.


Expected launch – Q3 2026

IQ-Flow

Triple-action Endoscopic Cyclophotocoagulation device.


Expected launch – Q1 2028

IQ-BioStim

Non-invasive acute and long-term therapy.


Expected launch – Q3 2026

IQ-Universe

Secured data cloud.

IQ-Scan
IQ-Meter
IQ-SurgiView
IQ-Guard
IQ-Focus
IQ-Flow
IQ-BioStim
IQ-Universe
2025
2026
2027
2028
2029
Logo Image

IQity

January is Glaucoma Awareness Month.

Glaucoma continues to be one of the leading causes of irreversible blindness worldwide, often advancing quietly until vision loss becomes significant. That reality makes early diagnosis, thoughtful intervention, and efficient clinical workflows more important than ever.

At IQity, glaucoma is central to the problems we are working to solve. Across diagnostics and treatment, we are building technologies designed to support better outcomes while reducing complexity, saving clinician time, and lowering the overall cost of care.

Progress in glaucoma care is not about adding more tools.
It is about enabling smarter decisions, smoother workflows, and solutions that scale in real world practice.

This month is a reminder that meaningful change happens when insight, technology, and clinical reality are connected from start to finish.

#GlaucomaAwarenessMonth #GlaucomaCare #Ophthalmology #PatientSafety #MedicalInnovation #DigitalHealth #IQity

LinkedIn Post Image
Visit post
Logo Image

IQity

How effective is ECP when combined with phaco? The evidence is clear.

A recent study in the Pan-American Journal of Ophthalmology found that glaucoma patients undergoing phaco ECP experienced greater and more sustained IOP reduction compared with phaco alone, along with a reduced need for glaucoma medications.

ECP is one of the most well studied and well understood glaucoma procedures available. Yet for decades, high capital costs, fragile light fibers, and limited innovation have held it back from broader adoption.

We believe that needs to change.

With IQ Flow, we are rethinking how ECP is delivered, removing unnecessary barriers and bringing modern design to a proven approach in glaucoma care.

#IQFlow #Glaucoma #Ophthalmology #ECP #SurgicalInnovation #ClinicalEvidence #IOPReduction

Edward Hu Young Choi Sean Ianchulev MD MPH James Simms

Read the document here

Visit post
Logo Image

IQity

We’ll be opening the first contingent of IQity demo slots for ASCRS 2026 shortly.

These hands-on sessions will give surgeons early access to the most mature versions yet of IQ-Flow, IQ-Meter and IQ-SurgiView and more – experienced as an integrated workflow.

Details and registration will follow soon. Watch this space!

LinkedIn Post Image
Visit post
Logo Image

IQity

More technology does not automatically mean better surgery.

In many operating rooms, it adds more steps, more interfaces, more complexity, and higher cost.

The real opportunity is simplification.
Designing systems that reduce friction, not add to it.

#Iqity #Simplification #Ophthalmology

James Simms Yousuf Khalifa Sascha Burger Steve Wilmarth, MD Daniel Chang

LinkedIn Post Image
Visit post
Logo Image

IQity

In ophthalmology, it’s getting harder to separate signal from noise.

There is a lot happening in ophthalmology right now, and not much time to sort through it all.

IQ Signal is how we share what we are seeing and learning, directly with you. A concise newsletter focused on emerging technologies and the conversations that matter for real world practice.

No spam. No fluff.
Just the insights that matter for daily practice and long-term planning. 

Visit https://lnkd.in/enpZUXZ6 to learn more and subscribe.

#IQity #IQSignal #Ophthalmology 

Jaime Martiz Daniel Chang Steve Wilmarth, MD Sascha Burger James Simms

LinkedIn Post Image
Visit post
Logo Image

IQity

A new year brings fresh momentum and a clear milestone ahead. ASCRS 2026 is 100 days away.

Over the past months, we’ve been building, testing, refining, and listening closely to surgeons. What we’ll be sharing at ASCRS reflects that work.

We’re not ready to reveal everything just yet; but for those paying attention to where ophthalmic surgery is heading, this is one to watch. 

#ASCRS2026 #IQity

LinkedIn Post Image
Visit post
Logo Image

IQity

Here’s to a new year of purposeful innovation, smarter systems, and better outcomes in ophthalmology. Happy New Year from the IQity team.

#IQity #Ophthalmology #Innovation #DigitalHealth #PatientCare #2026Vision

LinkedIn Post Image
Visit post
Logo Image

IQity

From all of us at IQity, Merry Christmas. 
Thank you to our partners, clinicians, and collaborators for being part of a year shaped by progress, trust, and shared purpose.

#IQity #Ophthalmology #MedicalInnovation #HealthcareTechnology #Partnerships #SeasonGreetings

LinkedIn Post Image
Visit post
Logo Image

IQity

Achieving consistent visual outcomes remains one of the most complex challenges in ophthalmology.

Clinical research continues to show how variability across patients, procedures, and postoperative conditions can influence IOL performance and patient satisfaction. Too often, managing that variability depends on manual calculations, fragmented data, and subjective judgment.

At IQity, we address this challenge with technology designed to reduce human error. Swipe to see 
→ Swipe to see how IQity is looking to support your practice.

#IQity #Ophthalmology #IOL #VisualOutcomes #MedicalInnovation #PatientSafety #ConnectedCare

Visit post
Logo Image

IQity

Even with near-universal EHR adoption, much of ophthalmic data is still captured and reviewed manually. This creates inefficiencies that introduce error, consume clinician time, and limit scalability.

Research from other surgical fields shows that manual chart review can carry error rates of approximately 10% and take several minutes per case, while automated data queries deliver faster and more reliable results.

At IQity, we believe ophthalmology deserves better systems.
→ Swipe to see how IQity is looking to support your practice. 

Jaime Martiz Daniel Chang Steve Wilmarth, MD Yousuf Khalifa Sascha Burger James Simms 

Efficiency isn’t just about speed. It’s about designing systems that work. 

#IQity #Ophthalmology #HealthIT #MedicalInnovation #PatientSafety #ClinicalEfficiency #DigitalHealth

Read the document here

Visit post

Leadership


Luke Clauson

Luke Clauson

CEO

Board


Farrell (Toby) Tyson

Farrell (Toby) Tyson

Luke Clauson

Luke Clauson

Jim Simms

Jim Simms

Advisory Board


Ike Ahmed, M.D.

Ike Ahmed, M.D.

Barry Seibel, M.D.

Barry Seibel, M.D.

Daniel Chang, M.D.

Daniel Chang, M.D.

Ed Hu, M.D.

Ed Hu, M.D.

Team


Matt Schuster

Matt Schuster

Engineering

Ed Sarver

Ed Sarver

Engineering

Gary Mocnik

Gary Mocnik

Regulatory & Clinical

Neville Bonwit

Neville Bonwit

Operations

Sascha Burger

Sascha Burger

Marketing

Karen Joyce

Karen Joyce

Administration